{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T18:15:58Z","timestamp":1693246558235},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00380-016-0832-z","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T11:09:06Z","timestamp":1459940946000},"page":"47-54","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ezetimibe enhances and stabilizes anticoagulant effect of warfarin"],"prefix":"10.1007","volume":"32","author":[{"given":"Takehiro","family":"Hashikata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Yamaoka-Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyoshi","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Fujiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Namba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kitasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Shimohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"key":"832_CR1","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","volume":"30","author":"EW Davie","year":"1991","unstructured":"Davie EW, Fujikawa K, Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30:10363\u201310370","journal-title":"Biochemistry"},{"key":"832_CR2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0037-1614485","volume":"81","author":"A Lubetsky","year":"1999","unstructured":"Lubetsky A, Dekel-Stern E, Chetrit A, Lubin F, Halkin H (1999) Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thromb Haemost 81:396\u2013399","journal-title":"Thromb Haemost"},{"key":"832_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-015-0694-9","author":"M Tagaya","year":"2015","unstructured":"Tagaya M, Yoshikawa D, Sugishita Y, Yamauchi F, Ito T, Kamada T, Yoshinaga M, Mukaide D, Fujiwara W, Yokoi H, Hayashi M, Watanabe E, Ishii J, Ozaki Y, Izawa H (2015) Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution. Heart Vessels. doi: 10.1007\/s00380-015-0694-9","journal-title":"Heart Vessels"},{"key":"832_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-015-0777-7","author":"K Yodogawa","year":"2015","unstructured":"Yodogawa K, Mii A, Fukui M, Iwasaki YK, Hayashi M, Kaneko T, Miyauchi Y, Tsuruoka S, Shimizu W (2015) Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation. Heart Vessels. doi: 10.1007\/s00380-015-0777-7","journal-title":"Heart Vessels"},{"key":"832_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-015-0694-9","author":"M Tagaya","year":"2015","unstructured":"Tagaya M, Yoshikawa D, Sugishita Y, Yamauchi F, Ito T, Kamada T, Yoshinaga M, Mukaide D, Fujiwara W, Yokoi H, Hayashi M, Watanabe E, Ishii J, Ozaki Y, Izawa H (2015) Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution. Heart Vessels. doi: 10.1007\/s00380-015-0694-9","journal-title":"Heart Vessels"},{"key":"832_CR6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","volume":"106","author":"T Sudhop","year":"2002","unstructured":"Sudhop T, Lutjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K (2002) Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106:1943\u20131948","journal-title":"Circulation"},{"key":"832_CR7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2004.02.060","volume":"93","author":"CM Ballantyne","year":"2004","unstructured":"Ballantyne CM, Blazing MA, King TR, Brady WE, Palmisano J (2004) Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia. Am J Cardiol 93:1487\u20131494","journal-title":"Am J Cardiol"},{"key":"832_CR8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387\u20132397","journal-title":"N Engl J Med"},{"issue":"1","key":"832_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00380-012-0243-8","volume":"28","author":"T Tobaru","year":"2013","unstructured":"Tobaru T, Seki A, Asano R, Sumiyoshi T, Hagiwara N (2013) Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease. Heart Vessels 28(1):39\u201345","journal-title":"Heart Vessels"},{"key":"832_CR10","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1056\/NEJMoa1405386","volume":"371","author":"NO Stitziel","year":"2014","unstructured":"Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, K\u00f6nig I, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O\u2019Donnell CJ, Abecasis G, Sunyaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Ye Z, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S (2014) Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med 371:2072\u20132082","journal-title":"N Engl J Med"},{"key":"832_CR11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","volume":"303","author":"SW Altmann","year":"2004","unstructured":"Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP (2004) Niemann\u2013Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201\u20131204","journal-title":"Science"},{"key":"832_CR12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mnfr.201000553","volume":"55","author":"E Reboul","year":"2011","unstructured":"Reboul E, Goncalves A, Comera C, Bott R, Nowicki M, Landrier JF, Jourdheuil-Rahmani D, Dufour C, Collet X, Borel P (2011) Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res 55:691\u2013702","journal-title":"Mol Nutr Food Res"},{"key":"832_CR13","doi-asserted-by":"crossref","first-page":"275ra23","DOI":"10.1126\/scitranslmed.3010329","volume":"7","author":"T Takada","year":"2015","unstructured":"Takada T, Yamanashi Y, Konishi K, Yamamoto T, Toyoda Y, Masuo Y, Yamamoto H, Suzuki H (2015) NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy. Sci Transl Med 7:275ra23","journal-title":"Sci Transl Med"},{"key":"832_CR14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/nure.12026","volume":"71","author":"P Borel","year":"2013","unstructured":"Borel P, Preveraud D, Desmarchelier C (2013) Bioavailability of vitamin E in humans: an update. Nutr Rev 71:319\u2013331","journal-title":"Nutr Rev"},{"key":"832_CR15","doi-asserted-by":"crossref","first-page":"8s","DOI":"10.1378\/chest.119.1_suppl.8S","volume":"119","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D (2001) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119:8s\u201321s","journal-title":"Chest"},{"key":"832_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jjcc.2014.07.013","volume":"65","author":"T Yamashita","year":"2015","unstructured":"Yamashita T, Inoue H, Okumura K, Atarashi H, Origasa H (2015) Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: a J-RHYTHM Registry analysis. J Cardiol 65:175\u2013177","journal-title":"J Cardiol"},{"key":"832_CR17","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1021\/ja01473a020","volume":"83","author":"BD West","year":"1961","unstructured":"West BD, Preis S, Schroeder CH, Link KP (1961) Studies on the 4-hydroxycoumarins. XVII.1a the resolution and absolute configuration of warfarin1b. J Am Chem Soc 83:2676\u20132679","journal-title":"J Am Chem Soc"},{"key":"832_CR18","first-page":"19","volume":"15","author":"A Breckenridge","year":"1978","unstructured":"Breckenridge A (1978) Oral anticoagulant drugs: pharmacokinetic aspects. Semin Hematol 15:19\u201326","journal-title":"Semin Hematol"},{"key":"832_CR19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2217\/pgs.12.151","volume":"13","author":"MR Botton","year":"2012","unstructured":"Botton MR, Hutz MH, Suarez-Kurtz G (2012) Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin. Pharmacogenomics 13:1557\u20131559 (author reply 1561\u20131562)","journal-title":"Pharmacogenomics"},{"key":"832_CR20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","volume":"165","author":"AM Holbrook","year":"2005","unstructured":"Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095\u20131106","journal-title":"Arch Intern Med"},{"key":"832_CR21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1592\/phco.21.9.884.34559","volume":"21","author":"SL Ravnan","year":"2001","unstructured":"Ravnan SL, Locke C (2001) Levofloxacin and warfarin interaction. Pharmacotherapy 21:884\u2013885","journal-title":"Pharmacotherapy"},{"issue":"350","key":"832_CR22","first-page":"352","volume":"20","author":"GD Wood","year":"1993","unstructured":"Wood GD, Deeble T (1993) Warfarin: dangers with antibiotics. Dent Update 20(350):352\u2013353","journal-title":"Dent Update"},{"key":"832_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00007691-198903000-00010","volume":"11","author":"T Sutfin","year":"1989","unstructured":"Sutfin T, Balmer K, Bostrom H, Eriksson S, Hoglund P, Paulsen O (1989) Stereoselective interaction of omeprazole with warfarin in healthy men. Ther Drug Monit 11:176\u2013184","journal-title":"Ther Drug Monit"},{"key":"832_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00003088-200544050-00002","volume":"44","author":"T Kosoglou","year":"2005","unstructured":"Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Bergman AJ, Alton KB (2005) Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 44:467\u2013494","journal-title":"Clin Pharmacokinet"},{"key":"832_CR25","first-page":"309","volume":"27","author":"RA O\u2019Reilly","year":"1972","unstructured":"O\u2019Reilly RA, Sahud MA, Robinson AJ (1972) Studies on the interaction of warfarin and clofibrate in man. Thromb Diath Haemorrh 27:309\u2013318","journal-title":"Thromb Diath Haemorrh"},{"key":"832_CR26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM196201112660205","volume":"266","author":"JC Owens","year":"1962","unstructured":"Owens JC, Neely WB, Owen WR (1962) Effect of sodium dextrothyroxine in patients receiving anticoagulants. N Engl J Med 266:76\u201379","journal-title":"N Engl J Med"},{"key":"832_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(00)00404-4","volume":"153","author":"TA Miettinen","year":"2000","unstructured":"Miettinen TA, Gylling H (2000) Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 153:241\u2013248","journal-title":"Atherosclerosis"},{"key":"832_CR28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1194\/jlr.M011080","volume":"52","author":"AJ Tremblay","year":"2011","unstructured":"Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR Jr, Couture P (2011) Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res 52:558\u2013565","journal-title":"J Lipid Res"},{"key":"832_CR29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","volume":"48","author":"DE Telford","year":"2007","unstructured":"Telford DE, Sutherland BG, Edwards JY, Andrews JD, Barrett PH, Huff MW (2007) The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. J Lipid Res 48:699\u2013708","journal-title":"J Lipid Res"},{"key":"832_CR30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4065\/80.5.587","volume":"80","author":"TA Pearson","year":"2005","unstructured":"Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J (2005) A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 80:587\u2013595","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"832_CR31","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/eci.12000","volume":"42","author":"H Takase","year":"2012","unstructured":"Takase H, Dohi Y, Okado T, Hashimoto T, Goto Y, Kimura G (2012) Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study. Eur J Clin Invest 42(12):1287\u20131294","journal-title":"Eur J Clin Invest"},{"key":"832_CR32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-8703(82)90292-7","volume":"103","author":"JC Forfar","year":"1982","unstructured":"Forfar JC (1982) Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio. Am Heart J 103:445\u2013446","journal-title":"Am Heart J"},{"key":"832_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","volume":"167","author":"HD White","year":"2007","unstructured":"White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW (2007) Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167:239\u2013245","journal-title":"Arch Intern Med"},{"key":"832_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199507063330102","volume":"333","author":"The European Atrial Fibrillation Trial Study Group","year":"1995","unstructured":"The European Atrial Fibrillation Trial Study Group (1995) Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 333:5\u201310","journal-title":"N Engl J Med"},{"key":"832_CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0167-5273(88)90165-9","volume":"18","author":"R Charney","year":"1988","unstructured":"Charney R, Leddomado E, Rose DN, Fuster V (1988) Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol 18:197\u2013206","journal-title":"Int J Cardiol"},{"key":"832_CR36","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2004-04-1525","volume":"104","author":"LJ Schurgers","year":"2004","unstructured":"Schurgers LJ, Shearer MJ, Hamulyak K, Stocklin E, Vermeer C (2004) Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose\u2013response relationships in healthy subjects. Blood 104:2682\u20132689","journal-title":"Blood"},{"key":"832_CR37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.amjmed.2003.12.036","volume":"116","author":"V Franco","year":"2004","unstructured":"Franco V, Polanczyk CA, Clausell N, Rohde LE (2004) Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 116:651\u2013656","journal-title":"Am J Med"},{"key":"832_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11239-007-0014-z","volume":"24","author":"SK Ford","year":"2007","unstructured":"Ford SK, Misita CP, Shilliday BB, Malone RM, Moore CG, Moll S (2007) Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios. J Thromb Thrombolysis 24:23\u201327","journal-title":"J Thromb Thrombolysis"},{"key":"832_CR39","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood-2006-09-049262","volume":"109","author":"E Sconce","year":"2007","unstructured":"Sconce E, Avery P, Wynne H, Kamali F (2007) Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 109:2419\u20132423","journal-title":"Blood"},{"key":"832_CR40","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1592\/phco.2005.25.12.1746","volume":"25","author":"AM Reese","year":"2005","unstructured":"Reese AM, Farnett LE, Lyons RM, Patel B, Morgan L, Bussey HI (2005) Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy 25:1746\u20131751","journal-title":"Pharmacotherapy"},{"issue":"2","key":"832_CR41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0004.2004.00388.x","volume":"67","author":"J Wang","year":"2005","unstructured":"Wang J, Williams CM, Hegele RA (2005) Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe. Clin Genet 67(2):175\u2013177","journal-title":"Clin Genet"},{"key":"832_CR42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-511X-4-16","volume":"4","author":"RA Hegele","year":"2005","unstructured":"Hegele RA, Guy J, Ban MR, Wang J (2005) NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Lipids Health Dis 4:16","journal-title":"Lipids Health Dis"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-016-0832-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0832-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T09:08:02Z","timestamp":1567760882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-016-0832-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1007\/s00380-016-0832-z","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,6]]}}}